Chengzhi Co., Ltd. (SHE:000990)
8.75
+0.14 (1.63%)
Jul 10, 2026, 3:04 PM CST
Chengzhi Market Cap
Chengzhi has a market cap or net worth of 10.63 billion as of July 10, 2026. Its market cap has increased by 13.93% in one year.
Market Cap
10.63B
Enterprise Value
14.47B
Revenue
10.87B
Ranking
n/a
PE Ratio
150.33
Stock Price
8.75
Market Cap Chart
Since January 2, 2001, Chengzhi's market cap has increased from 4.51B to 10.63B, an increase of 135.96%. That is a compound annual growth rate of 3.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 10.63B | 10.48% |
| Dec 31, 2025 | 9.62B | 2.19% |
| Dec 31, 2024 | 9.42B | -5.60% |
| Dec 29, 2023 | 9.98B | -6.70% |
| Dec 30, 2022 | 10.69B | -44.37% |
| Dec 31, 2021 | 19.23B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 11.57B |
| Shanghai Medicilon | 11.44B |
| Inner Mongolia Furui Medical Science | 11.42B |
| Tibet Cheezheng Tibetan Medicine | 11.36B |
| Beijing Hotgen Biotech | 10.94B |
| GemPharmatech | 10.41B |
| Hualan Biological Vaccine | 10.06B |
| Jiangxi Fushine Pharmaceutical | 9.87B |